SEC Filing Update: #TXG 10x Genomics, Inc. : $62.13

Sector: Healthcare | YTD: 🔼+ 274.05% The SEC disclosed Today (08-SEP-2026) that PRICE T ROWE ASSOCIATES INC MD has INCREASED #TXG Shares by 209.41% 🟢 * Previous Holdings: 4.54M Shares * Current Holdings: 14.04M Shares * Increase+9.51M * Increased(%)+209.41% * Ownership: 11.7% * Estimated Investment Value: $596.25M https://www.thinksabio.com/reports/isr/TXG The quarterly average prices of #TXG: Q3 2025: $13.04 Q4 2025: $15.09 Q1 2026: $20.00 Q2 2026: $26.20 📌 Institutional activity in the last 30 days for #TXG: • ARK INVESTMENT MANAGEMENT LLC – Increased holdings by 1 shares (14-AUG-2026) 📈 Stay ahead of institutional buy/sell moves — Sign up free at ThinkSabio: Sign Up Free → 🐦 See this update on X: https://x.com/Thinksabio/status/2097324779132915924 Price T Rowe Associates Inc increased its stake in TXG from 4,539,007 shares to 14,044,020 shares, representing 11.7% ownership of the healthcare company.